20-19212871-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020689.4(SLC24A3):c.29C>T(p.Ala10Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000333 in 1,247,942 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020689.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC24A3 | NM_020689.4 | c.29C>T | p.Ala10Val | missense_variant | 1/17 | ENST00000328041.11 | NP_065740.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC24A3 | ENST00000328041.11 | c.29C>T | p.Ala10Val | missense_variant | 1/17 | 1 | NM_020689.4 | ENSP00000333519.5 | ||
ENSG00000235996 | ENST00000446849.1 | n.347G>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 85AN: 148492Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.0000939 AC: 3AN: 31952Hom.: 0 AF XY: 0.0000517 AC XY: 1AN XY: 19354
GnomAD4 exome AF: 0.000301 AC: 331AN: 1099344Hom.: 0 Cov.: 29 AF XY: 0.000297 AC XY: 157AN XY: 528978
GnomAD4 genome AF: 0.000572 AC: 85AN: 148598Hom.: 1 Cov.: 31 AF XY: 0.000648 AC XY: 47AN XY: 72554
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.29C>T (p.A10V) alteration is located in exon 1 (coding exon 1) of the SLC24A3 gene. This alteration results from a C to T substitution at nucleotide position 29, causing the alanine (A) at amino acid position 10 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at